About Prenetics Global Ltd (PRE)

Prenetics Global Ltd (PRE) is a leading health technology company that focuses on personalized medicine and digital health. The company operates in multiple markets around the world, offering innovative solutions for genetic testing and health management. With a strong emphasis on research and development, Prenetics Global Ltd is at the forefront of advancements in DNA sequencing and analysis. Its mission is to empower individuals to take control of their health by providing them with actionable insights and personalized recommendations based on their genetic data. Through a combination of advanced technology and strategic partnerships, Prenetics Global Ltd aims to revolutionize the healthcare industry and enable better outcomes for patients.

As of the latest market close, Prenetics Global Ltd (PRE) had a market capitalization of $X billion. The company's stock price has had a volatile performance over the past year, with a 52-week range of $X to $Y. Despite this volatility, Prenetics Global Ltd has shown resilience and has consistently delivered strong financial results. The company's revenue has been growing at a steady pace, fueled by increasing demand for its genetic testing services. Prenetics Global Ltd has also made strategic acquisitions to expand its market reach and enhance its technological capabilities.